Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common stock, par value $ 0.000001 per share
-
Shares outstanding
-
6.51M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
2.75M
-
Shares change
-
-597K
-
Total reported value, excl. options
-
$57.3M
-
Value change
-
-$11M
-
Number of buys
-
16
-
Number of sells
-
-24
-
Price
-
$20.83
Significant Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) as of Q2 2025
49 filings reported holding TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share as of Q2 2025.
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.75M shares
of 6.51M outstanding shares and own 42.29% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (535K shares), CPMG Inc (411K shares), Vivo Capital, LLC (293K shares), Siren, L.L.C. (204K shares), VANGUARD GROUP INC (168K shares), GOLDMAN SACHS GROUP INC (163K shares), MILLENNIUM MANAGEMENT LLC (108K shares), MORGAN STANLEY (96.3K shares), Balyasny Asset Management L.P. (88.8K shares), and SECTORAL ASSET MANAGEMENT INC (86.2K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.